Human resources software startup Factorial has raised $150 million in funding at a valuation of $2.5 billion, making it one of the most highly valued startups in Spain. The Series D funding round was ...

General Catalyst leads $150M equity investment, its first equity stake in Factorial as part of Series D round that values the company at over $2.5 billion, becoming one of the most valuable AI ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

As Billerica battery company Factorial cruises into the public markets this week, it will have a veteran driver at its side: “Dr. Z.” Dieter Zetsche, one of the best-known executives in the car ...

“If you are a mathematician,” one of the world’s leading mathematicians recently wrote, “you may want to make sure you are sitting down before reading further.” And you’ll definitely need to sit down ...

Last week, OpenAI shocked the mathematical community by revealing that one of its internal artificial intelligence (AI) models had found a counterexample to a famous conjecture made by legendary ...

Recursion Pharmaceuticals is trying to solve a serious problem. Even with technological improvements, the time and costs required to develop brand-new drugs have increased in recent decades. It can ...

OpenAI claims its new reasoning model has produced an original mathematical proof disproving a famous unsolved conjecture in geometry, which was first posed by Paul Erdős in 1946. If this sounds ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Najat Khan looks at successful platform companies like Vertex, Regeneron and Alnylam and sees a path for Recursion to join them—if the company stays disciplined. (Recursion Pharmaceuticals) Chris ...